Medical Xpress August 12, 2024
Samuel (Sandy) Aronson, ALM, MA, executive director of IT and AI Solutions for Mass General Brigham Personalized Medicine and senior director of IT and AI Solutions for the Accelerator for Clinical Transformation, is the corresponding author of a paper published in NEJM AI that looked at whether generative AI could hold promise for improving scientific literature review of variants in clinical genetic testing. Their findings could have a wide impact beyond this use case.
How would you summarize your study for a lay audience?
We tested whether generative AI can be used to identify whether scientific articles contain information that can help geneticists determine whether genetic variants are harmful to patients. While testing this work, we identified inconsistencies in generative...
Today's Sponsors
Today's Sponsor